CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2022	Oct. 31, 2021
Cash flows from operating activities:
Net income	$ 73,702	$ 60,947
Adjustments to reconcile net (loss)/income to net cash used in operating activities:
Depreciation and amortization	8,218	9,401
Transactional (gains)/losses	(180)	(277)
Provision for inventories and accounts receivable	4,150	3,557
Deferred income taxes	(993)	909
Stock-based compensation	4,246	3,965
Other	190	234
Changes in assets and liabilities:
Trade receivables	(49,967)	(62,393)
Inventories	(66,150)	(23,755)
Other current assets	(2,712)	4,962
Accounts payable	(3,470)	2,033
Accrued liabilities	19,582	22,581
Accrued payroll and benefits	(9,190)	1,866
Income taxes receivable	9,494	17,216
Income taxes payable	(6,444)	(3,479)
Other non-current assets	(4,599)	637
Other non-current liabilities	474	290
Net cash (used in)/provided by operating activities	(23,649)	38,694
Cash flows from investing activities:
Capital expenditures	(4,703)	(3,637)
Long-term investments	(2,716)	(1,100)
Trademarks and other intangibles	(175)	(193)
Net cash used in investing activities	(7,594)	(4,930)
Cash flows from financing activities:
Repayment of bank borrowings	0	(21,140)
Dividends paid	(23,600)	(16,226)
Stock repurchase	(28,150)	(17,023)
Stock awards and options exercised and other changes	(80)	496
Other	(85)	(99)
Net cash used in financing activities	(51,915)	(53,992)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(7,349)	(1,786)
Net decrease in cash, cash equivalents and restricted cash	(90,507)	(22,014)
Cash, cash equivalents, and restricted cash at beginning of year	277,716	224,423
Cash, cash equivalents, and restricted cash at end of period	187,209	202,409
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	186,665	201,814
Restricted cash included in other non-current assets	544	595
Cash, cash equivalents, and restricted cash at end of period	$ 187,209	$ 202,409